These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21490239)

  • 1. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
    Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
    Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
    Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
    Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
    Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
    Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
    BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death receptor 4 variants and colorectal cancer risk.
    Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
    Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
    Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
    Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
    Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.